Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Molecules (Basel, Switzerland)|September 29, 2017
Current Development Status of MEK InhibitorsYing Cheng, Hongqi TianJournal of Drug Targeting|July 26, 2019
Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutationsLongfei Miao, Hongqi TianChemistry, an Asian Journal|May 19, 2018
N-Heterocyclic Carbene-Protected Ag Nanoparticles Immobilized on Polyacrylonitrile Fiber as Efficient Catalysts for a Three-Component Coupling ReactionJian Cao, Hongqi TianJournal of Drug Targeting|February 17, 2018
Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapyKui Li, Hongqi TianCurrent Medicinal Chemistry|June 20, 2019
Metal-Organic Framework (MOF)-Based Drug DeliveryJian Cao, Xuejiao Li, Hongqi TianBioinorganic Chemistry and Applications|November 8, 2018
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive LigandsXuejiao Li, Yahong Liu, Hongqi TianAsian Biomedicine : Research, Reviews and News|October 30, 2023
Evaluation of the radiosensitizing effect of MEK inhibitor KZ-001 on non-small cell lung cancer cells in vitroGongchao Huang, Wenqin Zhang, Hongqi TianThe Journal of Organic Chemistry|October 25, 2001
Asymmetric Strecker-Type Reaction of alpha-Aryl Ketones. Synthesis of (S)-alphaM4CPG, (S)-MPPG, (S)-AIDA, and (S)-APICA, the Antagonists of Metabotropic Glutamate ReceptorsDawei Ma, Hongqi Tian, Guixiang ZouNeuroscience|April 29, 2021
Neuroprotective Effect of a New Free Radical Scavenger HL-008 in an Ischemia-Reperfusion Injury Rat ModelYahong Liu, Ying Cheng, Wei Zhang, et al.Oxidative Medicine and Cellular Longevity|March 10, 2021
Preclinical Evaluation of Safety, Pharmacokinetics, Efficacy, and Mechanism of Radioprotective Agent HL-003Yahong Liu, Longfei Miao, Yuying Guo, et al.Pageof 4